Study of Natural Cytotoxicity Receptors in Patients with HIV/AIDS and Cancer: A Cross-Sectional Study
Table 5
Correlation analysis between NCRs and CD4 T cells, CD4/CD8 ratio, and days since HIV/AIDS diagnosis.
NKp30
CD4 T cells
CD4/CD8 ratio
Days since HIV/AIDS diagnosis
NK cells
Healthy donors
NKp46
0.7272
0.2585
−0.1408
NA
NKp30
—
0.1617
−0.0004
NA
HIV/AIDS group
NKp46
0.9046
0.2400
0.1928
0.0677
NKp30
—
0.2821
0.3249
0.1428
HIV/AIDSWC group
NKp46
0.7580
0.3351
0.0754
0.0948
NKp30
—
0.3677
0.2671
0.3910
CD56 NK subset
Healthy donors
NKp46
0.7838
0.2220
−0.1461
NA
NKp30
—
0.2208
0.0192
NA
HIV/AIDS group
NKp46
0.9297
0.2213
0.1986
0.0962
NKp30
—
0.3037 ()
0.3446
0.1946
HIV/AIDSWC group
NKp46
0.7156
0.3558
0.0864
0.1039
NKp30
—
0.3571
0.3112
0.4727
CD56 NK subset
Healthy donors
NKp46
0.7121
0.6241
0.0698
NA
NKp30
—
0.6232
0.2029
NA
HIV/AIDS group
NKp46
0.3303
0.3947
0.0571
0.2101
NKp30
—
0.0987
0.1911
0.3172
HIV/AIDSWC group
NKp46
0.8096
0.3094
−0.0091
−0.1055
NKp30
—
0.2354
0.0524
0.0975
The numbers are shown as “rs (p)”. . Significant p values are highlighted in bold. The correlation coefficient rs > 0 shows positive correlation; rs < 0 stands for negative correlation. and rs > 0.4 indicates the significant correlation between the two indexes. NA: not applicable.